Table 1.
Baseline | 2 Weeks | 4 Weeks | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Response (N=2,512) |
Remission (N = 2,477) |
Response (n=l,641) |
Remission (n=l,857) |
Response (n = 991) |
Remission (n=l,262) |
|||||||
Continuous Variables | Mean | SD | Mean | SD | Mean | SD | Mean | SD | Mean | SD | Mean | SD |
Age, y | 41.70 | 13.06 | 41.66 | 13.04 | 42.18 | 1.13 | 41.75 | 13.06 | 42.65 | 13.45 | 42.23 | 13.07 |
Age at onset of MDD, y | 25.23 | 14.17 | 25.20 | 14.14 | 25.55 | 14.37 | 24.98 | 14.04 | 25.39 | 14.83 | 25.05 | 14.40 |
Length of MDD, y | 16.44 | 13.29 | 16.44 | 13.30 | 16.60 | 13.52 | 16.74 | 13.36 | 17.23 | 13.73 | 17.18 | 13.51 |
Years of education | 13.73 | 3.22 | 13.73 | 3.22 | 13.78 | 3.17 | 13.85 | 3.21 | 13.79 | 3.16 | 13.89 | 3.17 |
Categorical variables | ||||||||||||
Income categorya | 1.49 | 1.13 | 1.51 | 1.13 | 1.49 | 1.14 | 1.49 | 1.13 | 1.46 | 1.14 | 1.47 | 1.13 |
Week 2 | ||||||||||||
Side effect intensityb | 1.98 | 1.66 | 1.97 | 1.64 | 1.89 | 1.58 | 1.89 | . 1.58 | ||||
Side effect frequencyb | 2.02 | 1.90 | 2.01 | 1.88 | 1.96 | 1.87 | 1.94 | 1.83 | ||||
Side effect burdenb | 1.37 | 1.48 | 1.33 | 1.44 | 1.26 | 1.35 | 1.23 | 1.31 | ||||
Symptom improvementc | 1.27 | 1.04 | 1.49 | 1.08 | 1.08 | 1.01 | 1.40 | 1.07 | ||||
Week 4 | ||||||||||||
Side effect intensityb | 1.84 | 1.64 | 1.83 | 1.62 | ||||||||
Side effect frequencyb | 1.88 | 1.89 | 1.88 | 1.88 | ||||||||
Side effect burdenb | 1.28 | 1.41 | 1.25 | 1.39 | ||||||||
Symptom improvementc | 1.34 | 1.06 | 1.69 | 1.07 | ||||||||
Binary variables | n | % | n | % | n | % | n | % | n | % | n | % |
|
|
|
|
|
|
|||||||
Employed | 1,563 | 63 | 1,563 | 63 | 990 | 61 | 1,139 | 62 | 581 | 60 | 758 | 61 |
Male gender | 918 | 37 | 904 | 36 | 620 | 38 | 688 | 37 | 376 | 38 | 470 | 37 |
Hispanic | 291 | 11 | 289 | 12 | 182 | 11 | 206 | 11 | 110 | 11 | 139 | 11 |
Race | ||||||||||||
White | 2,035 | 81 | 2002 | 81 | 1,360 | 83 | 1,543 | 83 | 817 | 82 | 1049 | 83 |
Black | 416 | 16 | 414 | 17 | 249 | 15 | 277 | 15 | 152 | 15 | 187 | 15 |
Family history of MDD | 1,393 | 56 | 1,368 | 56 | 906 | 56 | 1,046 | 57 | 546 | 55 | 710 | 57 |
Suicide attempts | 423 | 17 | 418 | 17 | 278 | 17 | 323 | 17 | 168 | 17 | 222 | 18 |
Axis I comorbidity | ||||||||||||
OCD | 272 | 11 | 270 | 11 | 167 | 10 | 192 | 10 | 94 | 10 | 129 | 10 |
PTSD | 420 | 17 | 416 | 17 | 276 | 17 | 318 | 17 | 173 | 18 | 227 | 18 |
Bulimia | 307 | 12 | 305 | 12 | 210 | 13 | 238 | 13 | 132 | 13 | 185 | 15 |
Panic disorder | 265 | 11 | 261 | 11 | 170 | 10 | 190 | 10 | 100 | 10 | 122 | 10 |
Agoraphobia | 233 | 09 | 228 | 09 | 144 | 09 | 171 | 09 | 79 | 08 | 108 | 09 |
Social phobia | 701 | 28 | 694 | 28 | 460 | 28 | 545 | 29 | 289 | 29 | 377 | 30 |
Alcohol dependence | 254 | 10 | 251 | 10 | 172 | 11 | 190 | 10 | 115 | 12 | 134 | 11 |
Substance dependence | 158 | 06 | 156 | 06 | 103 | 06 | 118 | 06 | 64 | 06 | 77 | 06 |
GAD | 498 | 20 | 490 | 20 | 340 | 21 | 389 | 21 | 208 | 21 | 260 | 21 |
Somatization disorder | 47 | 02 | 47 | 02 | 33 | 02 | 34 | 02 | 18 | 02 | 24 | 02 |
Hypochondriasis | 89 | 04 | 88 | 04 | 61 | 04 | 66 | 04 | 32 | 03 | 38 | 03 |
Primary care | 913 | 36 | 901 | 36 | 546 | 33 | 615 | 33 | 302 | 30 | 377 | 30 |
Marital status | ||||||||||||
Married | 888 | 35 | 871 | 35 | 592 | 36 | 656 | 35 | 356 | 36 | 443 | 35 |
Never married | 716 | 29 | 710 | 29 | 454 | 28 | 530 | 29 | 270 | 27 | 351 | 28 |
Divorced | 479 | 19 | 474 | 19 | 312 | 19 | 358 | 19 | 189 | 19 | 247 | 20 |
Widowed | 76 | 03 | 74 | 03 | 56 | 03 | 61 | 03 | 38 | 04 | 44 | 03 |
Cohabitant | 197 | 08 | 196 | 08 | 122 | 07 | 140 | 08 | 74 | 07 | 94 | 07 |
Separated | 155 | 06 | 151 | 06 | 105 | 06 | 112 | 06 | 64 | 06 | 83 | 07 |
Academic degree | ||||||||||||
Lower than high school | 266 | 11 | 263 | 11 | 169 | 10 | 181 | 10 | 97 | 10 | 120 | 10 |
High school degree | 1,515 | 60 | 1,494 | 60 | 986 | 60 | 1,116 | 60 | 602 | 61 | 755 | 60 |
Higher than high school | 730 | 29 | 719 | 29 | 486 | 30 | 560 | 30 | 292 | 29 | 387 | 31 |
History of SSRI resistance | 204 | 09 | 203 | 09 | 133 | 09 | 147 | 09 | 92 | 11 | 117 | 10 |
History of antidepressant resistance | 272 | 11 | 268 | 11 | 183 | 12 | 200 | 11 | 128 | 13 | 159 | 13 |
Response | ||||||||||||
QIDS (week 2) | 248 | 13 | 138 | 11 | ||||||||
QIDS (week 4) | 232 | 18 | ||||||||||
HDRS (week 12) | 1,339 | 53 | 783 | 48 | 416 | 42 | ||||||
Remission | ||||||||||||
QIDS (week 2) | 32 | 02 | 21 | 02 | ||||||||
QIDS (week 4) | 29 | 03 | ||||||||||
HDRS (week 12) | 1,023 | 41 | 709 | 38 | 410 | 32 |
Categories: 0=< $10,000; 1 = $10,000–$20,000; 2 = $20,000–$40,000; and 3 = > $40,000.
Side effects measured on a 7-point scale from 0 = none to 6 = intolerable.
QIDS improvement measured in categories: −1 = decrease, 0 = 0%–10%, 1 = 10%–20%, 2 = 20%–33%, 3 = 33%–49%.
Abbreviations: GAD = generalized anxiety disorder, HDRS = Hamilton Depression Rating Scale, MDD = major depressive disorder, OCD = obsessive-compulsive disorder, PTSD = posttraumatic stress disorder, QIDS = Quick Inventory of Depressive Symptomatology, SSRI = selective serotonin reuptake inhibitor.